These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32767235)

  • 1. Oncolytic Viruses and Their Potential as a Therapeutic Opportunity in Osteosarcoma.
    Wedekind MF; Cripe TP
    Adv Exp Med Biol; 2020; 1258():77-89. PubMed ID: 32767235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma.
    Morales-Molina A; Gambera S; Leo A; García-Castro J
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic viruses for potential osteosarcoma therapy.
    Hingorani P; Sampson V; Lettieri C; Kolb EA
    Adv Exp Med Biol; 2014; 804():259-83. PubMed ID: 24924179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic Viral Therapy in Osteosarcoma.
    Karadimas T; Huynh TH; Chose C; Zervoudakis G; Clampitt B; Lapp S; Joyce D; Letson GD; Metts J; Binitie O; Mullinax JE; Lazarides A
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining oncolytic HSV-1 with immunogenic cell death-inducing drug mitoxantrone breaks cancer immune tolerance and improves therapeutic efficacy.
    Workenhe ST; Pol JG; Lichty BD; Cummings DT; Mossman KL
    Cancer Immunol Res; 2013 Nov; 1(5):309-19. PubMed ID: 24777969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory.
    Martinez-Velez N; Laspidea V; Zalacain M; Labiano S; García-Moure M; Puigdelloses M; Marrodan L; Gonzalez-Huarriz M; Herrador G; de la Nava D; Ausejo-Mauleon I; Fueyo J; Gomez-Manzano C; Patiño-García A; Alonso MM
    Mol Cancer Ther; 2022 Mar; 21(3):471-480. PubMed ID: 34965961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells.
    Hasei J; Sasaki T; Tazawa H; Osaki S; Yamakawa Y; Kunisada T; Yoshida A; Hashimoto Y; Onishi T; Uno F; Kagawa S; Urata Y; Ozaki T; Fujiwara T
    Mol Cancer Ther; 2013 Mar; 12(3):314-25. PubMed ID: 23315976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturally oncolytic viruses.
    Roberts MS; Lorence RM; Groene WS; Bamat MK
    Curr Opin Mol Ther; 2006 Aug; 8(4):314-21. PubMed ID: 16955694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic Semliki forest virus vector as a novel candidate against unresectable osteosarcoma.
    Ketola A; Hinkkanen A; Yongabi F; Furu P; Määttä AM; Liimatainen T; Pirinen R; Björn M; Hakkarainen T; Mäkinen K; Wahlfors J; Pellinen R
    Cancer Res; 2008 Oct; 68(20):8342-50. PubMed ID: 18922906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Development and Characterization of a Next-Generation Oncolytic Virus Armed with an Anti-PD-1 sdAb for Osteosarcoma Treatment
    Higgins TA; Patton DJ; Shimko-Lofano IM; Eller TL; Molinari R; Sandey M; Ismail A; Smith BF; Agarwal P
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oncolytic virus therapy for malignant brain tumors].
    Ino Y; Todo T
    Brain Nerve; 2009 Jul; 61(7):815-22. PubMed ID: 19618859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Handling of the cotton rat in studies for the pre-clinical evaluation of oncolytic viruses.
    Cuddington B; Verschoor M; Mossman K
    J Vis Exp; 2014 Nov; (93):e52232. PubMed ID: 25490047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses.
    Cassady KA; Haworth KB; Jackson J; Markert JM; Cripe TP
    Viruses; 2016 Feb; 8(2):. PubMed ID: 26861381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic virotherapy for pancreatic ductal adenocarcinoma: A glimmer of hope after years of disappointment?
    Tassone E; Muscolini M; van Montfoort N; Hiscott J
    Cytokine Growth Factor Rev; 2020 Dec; 56():141-148. PubMed ID: 32859494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving gene therapy approaches for osteosarcoma using viral vectors: review.
    Witlox MA; Lamfers ML; Wuisman PI; Curiel DT; Siegal GP
    Bone; 2007 Apr; 40(4):797-812. PubMed ID: 17189720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses.
    Saito K; Shirasawa H; Isegawa N; Shiiba M; Uzawa K; Tanzawa H
    Oral Oncol; 2009 Dec; 45(12):1021-7. PubMed ID: 19833547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic adenoviruses as a therapeutic approach for osteosarcoma: A new hope.
    Garcia-Moure M; Martinez-Vélez N; Patiño-García A; Alonso MM
    J Bone Oncol; 2017 Nov; 9():41-47. PubMed ID: 29226089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unleashing the therapeutic potential of oncolytic viruses.
    Bommareddy PK; Kaufman HL
    J Clin Invest; 2018 Apr; 128(4):1258-1260. PubMed ID: 29504947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic vesicular stomatitis virus administered by isolated limb perfusion suppresses osteosarcoma growth.
    Kubo T; Shimose S; Matsuo T; Fujimori J; Sakaguchi T; Yamaki M; Shinozaki K; Woo SL; Ochi M
    J Orthop Res; 2011 May; 29(5):795-800. PubMed ID: 21437961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Delivery of IL-12 Adjuvants Immunotherapy by Oncolytic Viruses.
    Vannini A; Leoni V; Campadelli-Fiume G
    Adv Exp Med Biol; 2021; 1290():67-80. PubMed ID: 33559855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.